Over 1,000 suspected dementia sufferers are to be offered a potentially revolutionary Alzheimer's blood test. UCL scientists leading the trial believe the test will improve the accuracy of diagnosis from 70% to more than 90%. The test measures a biomarker called p-tau217 — associated with the build-up of harmful proteins in the brain — and will be used alongside traditional…
Ben KempSeptember 16, 2025


